Barbara Kahn, Director at DEXCOM INC (DXCM), sold 7,000 shares at $386.31 ($2.7M) on 2020-06-10, disclosed to the SEC on 2020-06-12.
Seasonal sale ($2.7M) by Director — this insider has traded DXCM in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $372.61 | 100 | $37K | 1.4% |
| 2 | $374.17 | 500 | $187K | 7.0% |
| 3 | $375.11 | 900 | $338K | 12.7% |
| 4 | $376.17 | 300 | $113K | 4.2% |
| 5 | $377.61 | 600 | $227K | 8.5% |
| 6 | $378.87 | 400 |
| $152K |
| 5.7% |
| 7 | $380.01 | 500 | $190K | 7.1% |
| 8 | $381.09 | 400 | $152K | 5.7% |
| 9 | $382.25 | 300 | $115K | 4.3% |
| 10 | $383.37 | 400 | $153K | 5.8% |
| 11 | $384.43 | 500 | $192K | 7.2% |
| 12 | $385.34 | 1,900 | $732K | 27.5% |
| 13 | $386.31 | 200 | $77K | 2.9% |
| Total | $380.71 avg | 7,000 | $2.7M | 100% |
| Filing → |
| DXCM | SELL | 2019-01-16 | $3.0M | — | Filing → |
| DXCM | SELL | 2017-11-20 | $164K | — | Filing → |
| DXCM | SELL | 2017-03-16 | $232K | — | Filing → |